AMC
GSK icon

Asset Management Corp’s GSK GSK Stock Holding History

Asset Management Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,423
Closed -$241K – 169
2022
Q1 		$241K Buy
4,423
+1
+0% +$54 0.12% 154
2021
Q4 		$244K Buy
4,422
+3
+0.1% +$156 0.12% 155
2021
Q3 		$211K Sell
4,419
-52
-1% -$2.61K 0.11% 172
2021
Q2 		$223K Buy
+4,471
New +$215K 0.13% 157
2021
Q1 		– Sell
-4,413
Closed -$212K – 195
2020
Q4 		$212K Buy
4,413
+3
+0.1% +$138 0.12% 152
2020
Q3 		$208K Buy
4,410
+1
+0% +$50 0.13% 141
2020
Q2 		$225K Buy
4,409
+2
+0% +$103 0.14% 110
2020
Q1 		$209K Buy
4,407
+1
+0% +$53 0.19% 105
2019
Q4 		$259K Buy
+4,406
New +$245K 0.18% 128

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Asset Management Corp's GSK Position: Q2 2022 in Review

Asset Management Corp sold out of GSK (GSK) in Q2 2022, closing a stake of 4,423 shares — an estimated $241K sold.

Asset Management Corp first reported a position in GSK in Q4 2019 and held it in 9 quarters. The position peaked at $259K in Q4 2019. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Asset Management Corp reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Asset Management Corp sold 4,423 GSK shares in Q2 2022, an estimated $241K.
  • Asset Management Corp first reported a position in GSK in Q4 2019 and held it in 9 quarters.
  • Asset Management Corp's GSK position peaked at $259K in Q4 2019.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Asset Management Corp's 13F filing for Q2 2022, filed 1 Aug 2022.